Search results for KIFC1 Antibody

KIFC1 Antibody#12313, Cell Signaling Technology (CST), 12313

KIFC1 Antibody recognizes endogenous levels of total KIFC1 protein.

KIFC1 Antibody#72054, Cell Signaling Technology (CST), 72054

KIFC1 Antibody recognizes endogenous levels of total KIFC1 protein.

KIFC1 Antibody (YA3142), MedChemexpress, HY-P83397

KIFC1 Antibody (YA3142) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to KIFC1.

Anti-KIFC1 Antibody (R2N98), AntibodySystem, RHN59102

Anti-KIFC1 Antibody (R1A12), AntibodySystem, RHN59101

Anti-KIFC1 antibody [11445], Abcam, AB172620

What is this antibody validated in? Anti-KIFC1 antibody [11445] (ab172620) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of KIFC1? Anti-KIFC1 [11445] (ab172620) specifically detects a band for KIFC1 (UniProt: Q9BW19) at a molecular weight of 74kDa. Trusted by the scientific community Anti-KIFC1 [11445] (ab172620) was first used in a scientific publication in 2013 and has been cited over 10 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-KIFC1 antibody [11445] (ab172620) has been confirmed by Western blot testing in KIFC1 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [11445] also available for your convenience: ab172620, Alexa Fluor® 647 - ab225237 , Alexa Fluor® 488 - ab225238 , Carrier free - ab235994 , PE - ab306126 , APC - ab306127 , HRP - ab306128 , Alkaline Phosphatase - ab308693 , Alexa Fluor® 594 - ab310401 , Alexa Fluor® 555 - ab311928 , Alexa Fluor® 568 - ab312399 , Alexa Fluor® 750 - ab321171 Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-KIFC1 antibody [11445], Abcam, AB306126

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-KIFC1 antibody [11445], Abcam, AB306127

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

KIFC1 Antibody (YA3142)(PBS only), MedChemexpress, HY-P83397A

KIFC1 Antibody (YA3142) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to KIFC1.

HRP Anti-KIFC1 antibody [11445], Abcam, AB306128

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .